Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellectis (CLLS) Net Income towards Common Stockholders: 2015-2023

Historic Net Income towards Common Stockholders for Cellectis (CLLS) over the last 9 years, with Sep 2023 value amounting to -$17.5 million.

  • Cellectis' Net Income towards Common Stockholders rose 38.59% to -$17.5 million in Q3 2023 from the same period last year, while for Sep 2023 it was -$86.1 million, marking a year-over-year increase of 17.49%. This contributed to the annual value of -$106.1 million for FY2022, which is 7.06% up from last year.
  • As of Q3 2023, Cellectis' Net Income towards Common Stockholders stood at -$17.5 million, which was down 49.33% from -$11.7 million recorded in Q2 2023.
  • In the past 5 years, Cellectis' Net Income towards Common Stockholders ranged from a high of $20.1 million in Q1 2020 and a low of -$40.6 million during Q4 2020.
  • Its 3-year average for Net Income towards Common Stockholders is -$25.4 million, with a median of -$26.8 million in 2022.
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first plummeted by 360.96% in 2019, then surged by 231.70% in 2020.
  • Over the past 5 years, Cellectis' Net Income towards Common Stockholders (Quarterly) stood at -$37.2 million in 2019, then decreased by 9.13% to -$40.6 million in 2020, then surged by 38.44% to -$25.0 million in 2021, then decreased by 7.27% to -$26.8 million in 2022, then skyrocketed by 38.59% to -$17.5 million in 2023.
  • Its Net Income towards Common Stockholders stands at -$17.5 million for Q3 2023, versus -$11.7 million for Q2 2023 and -$30.1 million for Q1 2023.